Human metapneumovirus SH protein promotes JAK1 degradation to impair host IL-6 signaling

Adam Brynes1,2, Yu Zhang2, John V Williams2

  • 1Program in Microbiology and Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Journal of Virology
|October 16, 2024
PubMed

Insights

Human metapneumovirus (HMPV) small hydrophobic (SH) protein inhibits IL-6 and interferon signaling by promoting JAK1 degradation. This immune evasion mechanism is crucial for HMPV replication and pathogenesis.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Human metapneumovirus (HMPV) causes significant respiratory illness, particularly in vulnerable populations.
  • HMPV employs viral proteins to evade host immune responses, but these mechanisms are not fully understood.
  • The HMPV small hydrophobic (SH) protein is implicated in inhibiting interferon (IFN) signaling.

Purpose of the Study:

  • To investigate the role of the HMPV SH protein in inhibiting IL-6 signaling.
  • To elucidate the molecular mechanisms by which SH protein interferes with host immune signaling pathways.

Main Methods:

  • Utilized SH expression plasmids and SH-deleted HMPV (ΔSH) virus.
  • Assessed IL-6-mediated STAT3 activation and JAK1 protein levels.
  • Employed proteasome inhibitors, confocal microscopy, and co-immunoprecipitation assays.

Main Results:

  • SH protein was identified as the viral factor inhibiting IL-6 signaling.
  • Wild-type HMPV infection, but not ΔSH virus, reduced JAK1 protein levels via proteasomal degradation.
  • SH protein was found to interact with JAK1 and ubiquitin, and JAK1 was relocalized to viral replication factories.

Conclusions:

  • HMPV SH protein inhibits IL-6 and IFN signaling by promoting JAK1 proteasomal degradation.
  • SH protein is essential for HMPV's ability to suppress host immune signaling during infection.
  • Understanding these immune evasion strategies is vital for developing therapeutics against severe HMPV infections.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.3K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K